About us Contact Terms of Use Data Sources Publications FAQ
PCSK2 logo

PCSK2

Neuroendocrine convertase 2

Expression

StudyTumor samplesMaxQ3Q2Q1MinNormal samplesMaxQ3Q2Q1MinLog2 (T vs N)
Adrenocortical (ACC) 77 2.33 0.66 0.09 -0.48 -0.02 126 2.38 1.44 0.34 -0.69 -0.02 -0.25
Bladder (BLCA) 406 2.26 -0.77 -0.70 -0.38 -0.00 9 1.54 1.32 1.23 0.70 0.25 -1.93
Breast (BRCA) 1067 2.69 -0.82 -0.73 -0.44 -0.00 178 1.48 0.64 0.25 -0.44 -0.01 -0.98
Cervical (CESC) 297 2.16 -0.76 -0.70 -0.46 -0.00 10 1.02 0.89 0.64 0.42 0.28 -1.34
Cholangiocarcinoma (CHOL) 36 1.72 -0.75 -0.70 -0.52 -0.09 0
Colon (COAD) 443 1.88 -0.73 -0.66 -0.35 -0.00 166 1.93 1.32 1.02 0.76 -0.09 -1.68
B-cell lymphoma (DLBC) 42 1.53 -0.75 -0.71 -0.47 -0.09 337 1.08 -0.63 -0.40 -0.23 -0.00 -0.31
Esophageal (ESCA) 142 2.15 0.28 -0.62 -0.34 -0.00 271 1.83 0.85 0.59 0.34 -0.04 -1.22
Glioblastoma (GBM) 160 2.23 1.40 1.04 0.56 -0.05 214 2.02 1.64 1.56 1.50 -0.09 -0.52
Head and neck (HNSC) 432 1.86 -0.74 -0.55 -0.32 -0.01 55 1.64 0.93 0.72 0.54 0.09 -1.27